Samer Srour

22PUBLICATIONS
84CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 24, 2026
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

|Jul 14, 2026
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial.

|Jul 06, 2026
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.

|Mar 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton

|Jan 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

|Apr 07, 2024
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma.

Sumanta K Pal, Ben Tran, John B A G Haanen

Pageof 4

Frequent Collaborators

10 joint publications

Yago Nieto

8 joint publications

Jeremy Ramdial

7 joint publications

Muzaffar Qazilbash

6 joint publications

Hans C Lee